In just a few years, oral nicotine pouches have gone from a niche cigarette alternative to a national fixation — and a ...

The groundbreaking decision is a win for harm reduction, though it also highlights absurd contradictions in the FDA's overall ...

Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.

Only time will tell what is next in the landscape of tobacco and nicotine regulation from the White House and the FDA.

The U.S. Food and Drug Administration (FDA) recently approved the marketing of 20 Zyn nicotine pouches, marking the first time nicotine pouches ...

The smoke-free champion marked an 11% rise in its duty-free business, which offset challenges in Australia and Korea’s ...

The Zyn case provides a good excuse for the administration to put the FDA on its radar. It’s beyond debate that smoking ...

Why did Swedish nicotine pouches become a generation's go-to fix for blasting through long work days and longer nights out?

Robert F. Kennedy Jr. is publicly advocating for health as he tries to get confirmed as secretary of health and human ...

Smoke-free products accounted for 40% of total net revenues, tobacco company Philip Morris International (PMI) said in ...

The recent authorization of ZYN oral nicotine pouches by the U.S. Food and Drug Administration (FDA) marks a major step forward in tobacco harm reduction.

On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.